Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
Canadian Journal of Physiology and Pharmacology|February 1, 1991
Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failureP J O'Brien, H Shen, J Weiler, et al.Journal of the American College of Cardiology|May 1, 1996
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)A Langer, S G Goodman, E J Topol, et al.The Canadian Journal of Cardiology|November 1, 1994
Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study GroupC D Morgan, M Gent, P A Daly, et al.Journal of the American College of Cardiology|June 1, 1991
Coronary patency, infarct size and left ventricular function after thrombolytic therapy for acute myocardial infarction: results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial. TPAT Study GroupC D Morgan, R S Roberts, A Haq, et al.Journal of General Microbiology|May 1, 1985
Phage pilH alpha: a phage which adsorbs to IncHI and IncHII plasmid-coded piliJ N Coetzee, D E Bradley, J Fleming, et al.Archives of Internal Medicine|February 15, 2001
Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and SurvivalB M Massie, P W Armstrong, J G Cleland, et al.Circulation|May 1, 1991
Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentrationG W Moe, E A Grima, C Angus, et al.Journal of the American College of Cardiology|June 1, 1995
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesA Langer, M W Krucoff, P Klootwijk, et al.European Heart Journal|November 10, 2000
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialL Rydén, P W Armstrong, J G Cleland, et al.European Heart Journal|May 1, 1996
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trialP Klootwijk, A Langer, S Meij, et al.Pageof 22